Who owns SYROS PHARMACEUTICALS INC?
- Ticker: SYRS
- CUSIP Number: 87184q206
Tip: Access positions for across all investors
Analyze quarterly positions in Syros Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Syros Pharmaceuticals stock
Who bought or sold SYROS PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Artal Group | 2.5M | $20M | 70% | Dec 2023 |
|
| Samsara BioCapital | 1.8M | $14M | 103% | Dec 2023 |
|
| Avidity Partners Management | 1.7M | $13M | 6% | Dec 2023 |
|
| Blue Owl Capital Holdings | 1.5M | $8.5M | 100% | Dec 2023 |
|
| Point72 Asset Management | 1.5M | $12M | 100% | Dec 2023 |
|
| Flagship Ventures Management | 1.3M | $10M | 30% | Dec 2023 |
|
| Vanguard Group | 765k | $6.0M | 45% | Dec 2023 |
|
| Opaleye Management | 359k | $2.8M | 100% | Dec 2023 |
|
| Omega Fund Management | 251k | $2.0M | 0% | Dec 2023 |
|
| Goldman Sachs Group | 240k | $1.9M | 125% | Dec 2023 |
|
| DAFNA Capital Management | 215k | $1.7M | -19% | Dec 2023 |
|
| Tang Capital Management | 85k | $662k | 100% | Dec 2023 |
|
| Lgt Capital Partners | 55k | $429k | 0% | Dec 2023 |
|
| Two Sigma Investments | 55k | $426k | 100% | Dec 2023 |
|
| 683 Capital Management | 36k | $284k | 100% | Dec 2023 |
|
| Assenagon Asset Management | 25k | $196k | 0% | Dec 2023 |
|
| Marshall Wace | 25k | $193k | 100% | Dec 2023 |
|
| T. Rowe Price Associates | 23k | $176k | 0% | Dec 2023 |
|
| 1492 Capital Management | 22k | $169k | 0% | Dec 2023 |
|
| Jane Street | 21k | $165k | 100% | Dec 2023 |
|
| Clarius | 19k | $100k | 0% | Mar 2024 |
|
| Citadel Advisors | 16k | $128k | 100% | Dec 2023 |
|
| HighTower Advisors | 15k | $117k | 0% | Dec 2023 |
|
| CI Private Wealth | 12k | $94k | -55% | Dec 2023 |
|
| Bank of America Corporation | 10k | $78k | 14637% | Dec 2023 |
|
| Edmond De Rothschild Holding | 4.4k | $34k | 0% | Dec 2023 |
|
| Royal Bank of Canada | 3.0k | $23k | 218% | Dec 2023 |
|
| Pnc Financial Services | 1.1k | $8.5k | 0% | Dec 2023 |
|
| Advisor Group Holdings | 1.1k | $8.4k | 266% | Dec 2023 |
|
| Russell Investments | 750.00 | $5.8k | 0% | Dec 2023 |
|
| Rhumbline Advisers | 659.00 | $5.1k | 0% | Dec 2023 |
|
| Jpmorgan Chase & Co | 549.00 | $4.3k | -49% | Dec 2023 |
|
| Wells Fargo & Company | 540.00 | $2.2k | -16% | Dec 2023 |
|
| IFP Advisors | 438.00 | $3.4k | 0% | Dec 2023 |
|
| Fifth Third Bancorp | 129.00 | $1.0k | 0% | Dec 2023 |
|
| Sound Income Strategies | 76.00 | $407.002800 | 0% | Mar 2024 |
|
| PSI Advisors | 13.00 | $100.999600 | 100% | Dec 2023 |
|
| Steward Partners Investment Advisory | 8.00 | $62.000000 | 100% | Dec 2023 |
|
Who sold out of Syros Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Shay Capital | Sep 2023 | 24k | $94k |
| UBS Group | Sep 2023 | 1.1k | $4.3k |
| Farther Finance Advisors | Sep 2023 | 20.00 | $79.000000 |